Discovery of eukaryotic cellular receptor for Withaferin A, a multifaceted drug from Withania somnifera plant
Withaferin A is a dietary natural compound from a very popular Ayurvedic plant called Ashwagandha (Withania Somnifera). Since the discovery of Withaferin A and its initial isolation and characterization in 1965, a plethora of elegant molecular and biochemical studies have shown the potent beneficial...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Withaferin A is a dietary natural compound from a very popular Ayurvedic plant called Ashwagandha (Withania Somnifera). Since the discovery of Withaferin A and its initial isolation and characterization in 1965, a plethora of elegant molecular and biochemical studies have shown the potent beneficial effects of this compound on various diseases including cancer and have strongly established Withaferin A as a potent multifaceted pharmaceutical drug. Recently, we have shown the anti-tumor effect of Withaferin A on the various hallmarks of Hepatocellular Carcinoma (HCC) via targeting nuclear receptor and transcription factor Liver X receptor-α (LXR-α). These studies have also shown the novel function of LXR-α and have established LXR-α as a specific cellular receptor for Withaferin A. In this mini-review, we discussed comprehensively some of the important supporting experimental evidences that led to the discovery of this new cellular nuclear receptor for Withaferin A. Here, we also discussed how Withaferin A acts on LXR-α and negatively regulates NF-κB transcription factor and ameliorates HCC proliferation, migration and invasion. |
|---|---|
| Item Description: | 2590-0986 10.1016/j.medidd.2022.100127 |